These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18938738)

  • 1. [Pharmacologic treatment of the ischaemic syndromes].
    Sánchez Cisneros N
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-257-63. PubMed ID: 18938738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coronary ischemic syndromes].
    Rivas Chícharo R
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-225-9. PubMed ID: 18938731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulant and thrombolytic agents in acute coronary syndromes].
    Schwarz M; Saurbier B; Bode C
    Hamostaseologie; 2008 Dec; 28(5):438-47. PubMed ID: 19132173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
    Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
    Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-ischemic therapy in patients with STEMI or NSTEMI treated at county and university hospitals].
    Raos V; Raguz M; Rajcan Spoljarić I; Vrazić H; Culo MI; Bergovec M
    Acta Med Croatica; 2009 Feb; 63(1):53-8. PubMed ID: 19681463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
    Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
    Gibson CM
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
    Sculpher MJ; Lozano-Ortega G; Sambrook J; Palmer S; Ormanidhi O; Bakhai A; Flather M; Steg PG; Mehta SR; Weintraub W
    Am Heart J; 2009 May; 157(5):845-52. PubMed ID: 19376310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Features and pathophysiology of acute coronary syndrome].
    Bergovec M; Vrazić H; Rajcan Spoljarić I; Raguz M; Stipcević M; Udovicić M
    Acta Med Croatica; 2009 Feb; 63(1):3-7. PubMed ID: 19681454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies.
    Goldstein P; Lapostolle F; Steg G; Danchin N; Assez N; Montalescot G; Charpentier S; Wiel E; Juliard JM
    Eur J Emerg Med; 2009 Oct; 16(5):244-55. PubMed ID: 19318957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
    Dziewierz A; Siudak Z; Dykla D; Rakowski T; Mielecki W; Dubiel JS; Dudek D
    Kardiol Pol; 2009 Feb; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic treatments in acute coronary syndromes with persistent ST-segment elevation].
    Aubry P; Halna du Fretay X
    Ann Cardiol Angeiol (Paris); 2010 Dec; 59(6):335-43. PubMed ID: 21056405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ischemic preconditioning and arterial collateral flow on ST-segment elevation and QRS complex prolongation in a canine model of acute coronary occlusion.
    Floyd JS; Maynard C; Weston P; Johanson P; Jennings RB; Wagner GS
    J Electrocardiol; 2009; 42(1):19-26. PubMed ID: 19070706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?
    Van de Werf F
    Eur Heart J; 2009 Jul; 30(14):1695-702. PubMed ID: 19491132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?
    Saucedo JF
    Am J Cardiol; 2009 Sep; 104(5 Suppl):4C-8C. PubMed ID: 19695354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.
    Karthikeyan G; Mehta SR; Eikelboom JW
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):241-9. PubMed ID: 19296760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for urgent coronary angiography. Part I: ST-segment elevation acute coronary syndromes].
    Iglesias JF; Roguelov C; Kabir T; Vogt P; Eeckhout E
    Rev Med Suisse; 2009 May; 5(205):1195-6, 1198-201. PubMed ID: 19517751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.